Impact of severe COVID-19 infection on coronary microvascular dysfunction in ANOCA patients: A cross-sectional study
Ali Aldujeli; Tsung-Ying Tsai; Ayman Haq; Kamile Puipaite; Rima Braukyliene; Vacis Tatarunas; Diana Zaliaduonyte; Ramunas Unikas; Mick Renkens; Pruthvi C. Revaiah; Kotaro...
Coronary “Microvascular Dysfunction”: Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics
Kei, Chun Yeung; Singh, Kuljit; Dautov, Rustem F.; Nguyen, Thanh H.; Chirkov, Yuliy Y.; Horowitz, John D.
Until recently, it has been generally held that stable...
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group
Vijay Kunadian, Alaide...
I wonder how much of medicine would be found to not be useful if it were tested against sham controls. Certainly a lot of alternative and complementary therapies wouldn't do well, I would think.
http://www.jwatch.org/fw113497/2017/11/03/study-pci-appears-no-better-sham-procedure-patients-with
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.